For women with chemo-resistant breast cancer, bisphosphonate treatment fails to impro

[News]

Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented at the 2013 San Antonio Breast Cancer Symposium.Many patients with breast cancer are treated with chemotherapy prior to surgery.

More... (http://www.medicalnewstoday.com/releases/270229.php)